49 related articles for article (PubMed ID: 14647427)
21. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
22. Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells.
Mizuno R; Oya M; Hara S; Matsumoto M; Horiguchi A; Ohigashi T; Marumo K; Murai M
Oncol Rep; 2005 Sep; 14(3):639-44. PubMed ID: 16077967
[TBL] [Abstract][Full Text] [Related]
23. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinase pathway controls autoimmune regulator (AIRE) gene expression in granulo-monocyte colony stimulating factor (GM-CSF)-stimulated myelomonocytic leukemia OTC-4 cells.
Nagafuchi S; Katsuta H; Ohno Y; Inoue Y; Shimoda K; Kogawa K; Ikeda Y; Koyanagi-Katsuta R; Yamasaki S; Tominaga H; Tamiya S; Umemura T; Otsuka T; Miyamoto T; Otsuka T; Harada M; Kudoh J; Shimizu N
Immunol Lett; 2005 Jun; 99(1):130-5. PubMed ID: 15894121
[TBL] [Abstract][Full Text] [Related]
25. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
26. Gfs chemicals.
Anal Chem; 1983 Feb; 55(2):231A. PubMed ID: 22742292
[No Abstract] [Full Text] [Related]
27. Gfs chemicals.
Anal Chem; 1981 Aug; 53(9):1109A. PubMed ID: 22742025
[No Abstract] [Full Text] [Related]
28. Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity.
Yamashiro H; Yoshizaki S; Tadaki T; Egawa K; Seo N
J Leukoc Biol; 2010 Oct; 88(4):757-67. PubMed ID: 20610803
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach.
Liu WM; Scott KA; Shamash J; Joel S; Powles TB
Leuk Lymphoma; 2008 Sep; 49(9):1800-9. PubMed ID: 18608861
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells.
Trost N; Stepisnik T; Berne S; Pucer A; Petan T; Komel R; Debeljak N
Radiol Oncol; 2013; 47(4):382-9. PubMed ID: 24294184
[TBL] [Abstract][Full Text] [Related]
31. The effect of erythropoietin on normal and neoplastic cells.
Elliott S; Sinclair AM
Biologics; 2012; 6():163-89. PubMed ID: 22848149
[TBL] [Abstract][Full Text] [Related]
32. Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents.
Bennett CL; Lai SY; Henke M; Barnato SE; Armitage JO; Sartor O
Arch Intern Med; 2010 Sep; 170(16):1490-8. PubMed ID: 20837837
[TBL] [Abstract][Full Text] [Related]
33. Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?
Hand CC; Brines M
J Investig Med; 2011 Oct; 59(7):1073-82. PubMed ID: 20683348
[TBL] [Abstract][Full Text] [Related]
34. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
35. Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway.
Fu P; Jiang X; Arcasoy MO
Biochem Biophys Res Commun; 2009 Feb; 379(3):696-701. PubMed ID: 19133231
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.
Márkász L; Hajas G; Kiss A; Lontay B; Rajnavölgyi E; Erdodi F; Oláh E
Pathol Oncol Res; 2008 Sep; 14(3):285-92. PubMed ID: 18493867
[TBL] [Abstract][Full Text] [Related]
37. Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity.
Liu WM; Powles T; Shamash J; Propper D; Oliver T; Joel S
Oncogene; 2004 Jan; 23(4):981-90. PubMed ID: 14647427
[TBL] [Abstract][Full Text] [Related]
38. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
[TBL] [Abstract][Full Text] [Related]
39. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
40. Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Int J Mol Med; 2005 Nov; 16(5):873-81. PubMed ID: 16211258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
